Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Total Liabilities (2016 - 2025)

Palisade Bio has reported Total Liabilities over the past 16 years, most recently at $5.0 million for Q4 2025.

  • Quarterly Total Liabilities rose 46.52% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 46.52% year-over-year, with the annual reading at $5.0 million for FY2025, 46.52% up from the prior year.
  • Total Liabilities was $5.0 million for Q4 2025 at Palisade Bio, up from $3.8 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $24.4 million in Q2 2021 and troughed at $1.2 million in Q1 2021.
  • The 5-year median for Total Liabilities is $3.3 million (2022), against an average of $4.7 million.
  • Year-over-year, Total Liabilities skyrocketed 2712.3% in 2021 and then crashed 85.26% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $5.1 million in 2021, then crashed by 36.2% to $3.3 million in 2022, then decreased by 16.6% to $2.7 million in 2023, then grew by 23.69% to $3.4 million in 2024, then skyrocketed by 46.52% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Total Liabilities are $5.0 million (Q4 2025), $3.8 million (Q3 2025), and $4.0 million (Q2 2025).